Epidemiology and treatment of neuropathic pain: The UK primary care perspective

Pain

Volumn 122, Issue 1-2, 2006, Pages 156-162

  Hall, Gillian C ^a   Carroll, Dawn ^b   Parry, David ^b   McQuay, Henry J ^c  

^a Grimsdyke House   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Incidence; Neuropathic pain; Primary care; Treatment

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; COCODAMOL; CODYDRAMOL; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DIHYDROCODEINE; OPIATE; PARACETAMOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIABETIC NEUROPATHY; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEUROPATHIC PAIN; PHANTOM PAIN; PHYSICIAN; POSTHERPETIC NEURALGIA; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TIME SERIES ANALYSIS; TRIGEMINUS NEURALGIA; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; CHILD; CHILD, PRESCHOOL; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; NEURALGIA; PRIMARY HEALTH CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 33646061619     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2006.01.030     Document Type: Article

References (31)

1. Boulton A.J., Knight G., Drury J., and Ward J.D. The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care 8 (1985) 125-128
2. Brewis M., Poskanzer D.C., Rolland C., and Miller H. Neurological disease in an English city. Acta Neurol Scand 42 Suppl. 24 (1966) 1-89
3. Brown G.R. Herpes zoster: correlation of age, sex, distribution, neuralgia, and associated disorders. South Med J 69 (1976) 576-578
4. Buchanan D., and Mandel A. The prevalence of phantom limb experience in amputees. Rehabil Psychol 31 (1986) 183-188
5. Chan A., MacFarlane I.A., Bowsher D., Wells J.C., Bessex C., and Griffiths K. Chronic pain in patients with diabetes mellitus: comparison with a non-diabetic population. Pain Clinic 3 (1990) 147-159
6. Cockerell O.C., Goodridge D.M., Brodie D., Sander J.W., and Shorvon S.D. Neurological disease in a defined population: the results of a pilot study in two general practices. Neuroepidemiology 15 (1996) 73-82
7. Crooks R.J., Jones D.A., and Fiddian A.P. Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scand J Infect Dis Suppl 80 (1991) 62-68
8. Department of Health. Hospital Episode Statistics, England. ; Financial year 2001-2002 [accessed November 2004].
9. Department of Health. PRODIGY Guidance - Shingles and postherpetic neuralgia. ; 2002a [accessed July 2004].
10. Department of Health. PRODIGY Guidance - Trigeminal neuralgia. ; 2002b [accessed September 2004].
11. Ehde D.M., Czerniecki J.M., Smith D.G., Campbell K.M., Edwards W.T., Jensen M.P., et al. Chronic phantom sensations, phantom pain, residual limb pain, and other regional pain after lower limb amputation. Arch Phys Med Rehabil 81 (2000) 1039-1044
12. Garcia Rodriguez L.A., and Perez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 45 (1998) 419-425
13. Hall G. Pharmacoepidemiology using a UK database of primary care records. Pharmacoepidemiol Drug Saf 1 (1992) 33-37
14. Helgason S., Petursson G., Gudmundsson S., and Sigurdsson J.A. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ 321 (2000) 794-796. http://bmj.bmjjournals.com/cgi/content/full/321/7264/794 http://bmj.bmjjournals.com/cgi/content/full/321/7264/794
15. Hope-Simpson R.E. Postherpetic neuralgia. J R Coll Gen Pract 25 (1975) 571-575
16. Jensen T.S., Krebs B., Nielsen J., and Rasmussen P. Non-painful phantom limb phenomena in amputees: incidence, clinical characteristics and temporal course. Acta Neurol Scand 70 (1984) 407-414
17. Johnson R.W., and Dworkin R.H. Treatment of herpes zoster and postherpetic neuralgia. BMJ 326 (2003) 748-750. http://bmj.bmjjournals.com/cgi/content/full/326/7392/748 http://bmj.bmjjournals.com/cgi/content/full/326/7392/748
18. Joint Formulary Committee. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary 48. ; 2004 [accessed January 2005].
19. Kalso E., Edwards J.E., Moore R.A., and McQuay H.J. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 112 (2004) 372-380
20. Katusic S., Beard C.M., Bergstralh E., and Kurland L.T. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol 27 (1990) 89-95
21. Kooijman C.M., Dijkstra P.U., Geertzen J.H., Elzinga A., and van der Schans C.P. Phantom pain and phantom sensations in upper limb amputees: an epidemiological study. Pain 87 (2000) 33-41
22. MacDonald B.K., Cockerell O.C., Sander J.W., and Shorvon S.D. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 123 Pt. 4 (2000) 665-676
23. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P.J., and Moore R.A. A systematic review of antidepressants in neuropathic pain. Pain 68 (1996) 217-227
24. Merrison A.F., and Fuller G. Treatment options for trigeminal neuralgia. BMJ 327 (2003) 1360-1361. http://bmj.bmjjournals.com/cgi/content/full/327/7428/1360 http://bmj.bmjjournals.com/cgi/content/full/327/7428/1360
25. Nabarro J.D. Diabetes in the United Kingdom: a personal series. Diabet Med 8 (1991) 59-68
26. National Statistics. Census 2001. ; 2001 [accessed January 2005].
27. NHS Centre for Coding and Classification. The READ Codes Version 3. London: Stationary Office; 1996.
28. NHS Scotland. Information and Statistics Division. The Amputee Statistical Database for the United Kingdom. [accessed August 2004].
29. O'Hare J.A., Abuaisha F., and Geoghegan M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir J Med Sci 163 (1994) 132-135
30. Perry J. Oxmis problem codes for primary medical care (1978), Oxmis Publications, Oxford
31. Young M.J., Boulton A.J., MacLeod A.F., Williams D.R., and Sonksen P.H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36 (1993) 150-154